BE876030A - Diesters d'ethylenesglycol, leur preparation et leur utilisation - Google Patents

Diesters d'ethylenesglycol, leur preparation et leur utilisation

Info

Publication number
BE876030A
BE876030A BE0/194982A BE194982A BE876030A BE 876030 A BE876030 A BE 876030A BE 0/194982 A BE0/194982 A BE 0/194982A BE 194982 A BE194982 A BE 194982A BE 876030 A BE876030 A BE 876030A
Authority
BE
Belgium
Prior art keywords
ethylenesglycol
diesters
preparation
ethylenesglycol diesters
Prior art date
Application number
BE0/194982A
Other languages
English (en)
Original Assignee
Alter Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alter Lab filed Critical Alter Lab
Publication of BE876030A publication Critical patent/BE876030A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BE0/194982A 1978-05-05 1979-05-04 Diesters d'ethylenesglycol, leur preparation et leur utilisation BE876030A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES469531A ES469531A1 (es) 1978-05-05 1978-05-05 Un procedimiento de preparacion de ciertos diesteres de eti-lenglicol.

Publications (1)

Publication Number Publication Date
BE876030A true BE876030A (fr) 1979-09-03

Family

ID=8476005

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/194982A BE876030A (fr) 1978-05-05 1979-05-04 Diesters d'ethylenesglycol, leur preparation et leur utilisation

Country Status (13)

Country Link
JP (1) JPS557263A (fr)
AR (1) AR221361A1 (fr)
BE (1) BE876030A (fr)
CA (1) CA1110247A (fr)
CH (1) CH640503A5 (fr)
DE (1) DE2917014C2 (fr)
ES (1) ES469531A1 (fr)
FR (1) FR2424901A1 (fr)
GB (1) GB2025393A (fr)
MX (1) MX5416E (fr)
NL (1) NL7903512A (fr)
PT (1) PT69569A (fr)
ZA (1) ZA792143B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1168389B (it) * 1981-05-06 1987-05-20 Alfa Farmaceutici Spa Derivati di alcandioli con attivita' ipolipidemizzante,metodi per la loro preparazione e composizioni farmaceutiche che li contengono
WO2003063681A2 (fr) * 2002-01-03 2003-08-07 Herbal 2000, Llc Procede et compose pour la prophylaxie ou le traitement d'une condition d'immunodeficience, telle que le sida

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES426755A1 (es) * 1974-05-29 1976-07-16 Alter Sa Un procedimiento de preparacion del ester mixto 1 - 2 - (p-clorofenoxi) - 2 - metilpropianoato, 2 - nicotinato de eti- lenglicol.
ES438245A1 (es) * 1975-06-04 1977-01-16 Alter Sa Procedimiento de purificacion del ester mixto 1-(2-(p-cloro-fenoxi)-2metilpropionato), 2-nicotinato de etilenglicol.

Also Published As

Publication number Publication date
PT69569A (en) 1979-06-01
AR221361A1 (es) 1981-01-30
CH640503A5 (de) 1984-01-13
ES469531A1 (es) 1978-12-01
DE2917014A1 (de) 1979-11-15
GB2025393A (en) 1980-01-23
NL7903512A (nl) 1979-11-07
CA1110247A (fr) 1981-10-06
FR2424901B1 (fr) 1981-04-30
DE2917014C2 (de) 1982-06-16
ZA792143B (en) 1980-05-28
MX5416E (es) 1983-07-27
FR2424901A1 (fr) 1979-11-30
JPS557263A (en) 1980-01-19

Similar Documents

Publication Publication Date Title
BE879586A (fr) Phosphinylalcanoyl prolines, leur preparation et leur utilisation
LU80886A1 (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes,et leur utilisation therapeutique
LU81439A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
BE884300A (fr) Amides, leur preparation et leur utilisation
LU80922A1 (fr) 9-amino-et imino-dibenzopyrannes et leur utilisation therapeutique
BE882601A (fr) Mercaptoacyldipeptides, leur preparation et leur utilisation
FR2494689B1 (fr) Xanthates, leur preparation et leur utilisation
BE880220A (fr) 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur utilisation therapeutique, leur preparation et les intermediaires appropries
FR2439197B1 (fr) 1-thia-3-aza-4-ones, substituees, leur preparation et leur utilisation en agriculture
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE871807A (fr) 4-quinolyl-guanidines, leur preparation et leur utilisation
BE887323A (fr) 17alpha-acyloxy-5 beta-corticoides et 17alpha-acyloxy-5alpha-corticoides, leur preparation et leur utilisation
BE885117A (fr) 3-amino-oxazolidin-2-ones, leur preparation et leur utilisation
BE882010A (fr) Tetrahydrobenzothiazolylimidazolidinones et leur utilisation
BE891585A (fr) 5 alpha-androstane-17 beta-carboxylates et 5 beta-androstane-17 beta-carboxylates, leur preparation et leur utilisation
BE866728A (fr) 1,2,4-triazoles, leur preparation et leur utilisation
BE878550A (fr) Oxazolines substituees et leur utilisation
BE894056A (fr) 2-oxo-azetidines, leur preparation et leur utilisation
LU81440A1 (fr) Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutique
BE880182A (fr) Nouvelles azepino (1,2,3-1m)-beta-carbolines et leur preparation
BE877263A (fr) 2-azaergolines et 2-aza-8 (ou 9) ergolenes et leur utilisation therapeutique
BE874430A (fr) 2,3-dihydroimidazo (1,2,c) pyrimidines substituees et leur utilisation therapeutique
BE884990A (fr) Thiadiazine-amines, leur preparation et leur utilisation
BE888608A (fr) Esters de steroide-oxazoles, leur preparation et leur utilisation,
BE876030A (fr) Diesters d'ethylenesglycol, leur preparation et leur utilisation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: LABORATORIOS ALTER S.A.

Effective date: 19860531